A Clinical Trial Networks Working Group (CTN WG) was recently established at the GloPID-R General Assembly in Seoul, South Korea on March 17, 2017. This newly created group’s purpose is to have a platform to further exchange information on best practices and lessons learned and find further synergies to work together. The CTN WG’s overarching goal is to support a rapid clinical research response to save populations when epidemics strike. Chaired by the European Commission, the group has participating representatives from…Read more

The importance of GloPID-R’s work, along with other initiatives, in research and development preparedness was mentioned at the G20 Health Ministers Meeting in Berlin, Germany on May 19 – 20, 2017. The G20 acknowledges that research and development (R&D) are necessary to quickly develop and provide quality medicines, diagnostics, vaccines and medical equipment during health outbreaks. To accelerate research efforts and timely data-sharing, it requires sustainable funding and effective, global coordination. “We welcome and support new models for R&D preparedness…Read more

The Data Sharing Principles were developed by the GloPID-R Data Sharing Working Group as the first step in the framework to be used in building a data sharing system. These principles have been developed to underpin the timely sharing of data by all stakeholders, which an effective and efficient response to a public health emergency (PHE) demands. When stakeholders commit to sharing data, they leverage limited resources and reduce duplication of work and the delay between identification of a PHE…Read more

Preparation is what’s needed for research funders to mobilize funds quickly when the WHO announces the next public health emergency of international concern (PHEIC). Increasing global preparedness will be the main theme at the Global Collaboration Research for Infectious Disease Preparedness (GloPID-R) fifth annual General Assembly in Seoul, South Korea on March 9-10, 2017. GloPID-R brings together 26 major research funders to facilitate an effective research response within 48 hours of a significant outbreak with pandemic potential to save lives…Read more

GloPID-R members hosted the “GloPID-R Zika Virus Research Workshop” in Sao Paulo, Brazil on November 30 – December 2, 2016 to facilitate collaboration between members on Zika funded research projects. The workshop’s aim was to identify and establish collaboration and synergies between the research and capacity development projects in support of the Zika virus response in Latin America and the Caribbean funded by GloPID-R members worldwide. The workshop brought together almost 70 participants, both funders and researchers, from nearly 50…Read more

GloPID-R is pleased to announce that the Egyptian Academy of Scientific Research & Technology (ASRT) and the UK Medical Research Council (MRC) have joined the network. With the addition of these two leading institutions, GloPID-R is now 25 members strong and continues to broaden its global scope. The Egyptian ASRT, represented by Dr. Amr Radwan, was established in 1971 as the national authority for science and technology in Egypt. As a funding agency, it has funding programs addressing local societal…Read more

The U.S. Agency for International Development (USAID) has announced it is investing more than $15 million in 21 awards to worldwide nominees offering solutions to ‘mitigate the spread and impact of the Zika virus’. The Combating Zika and Future Threats Grand Challenge was launched by USAID in April 2016. A total of up to $30 million is to be invested in innovative tools from all over the world to fight the current Zika outbreak and also to ensure that prevention,…Read more

A correspondence signed by GloPID-R stakeholders Marie-Paule Kieny of WHO, John-Arne Røttingen of the Norwegian Institute of Public Health and Jeremy Farrar of the Wellcome Trust was published in The Lancet on 30th July 2016. The letter highlights both the timeliness of the creation of the GloPID-R network of research funding organizations in 2013 and its complementarity with the research and development (R&D) Blueprint Initiative of WHO. The correspondence states the need for a coherent global response to the increasing…Read more

At the 42nd G7 summit hosted by Japan in Ise-Shima on the 26th and 27th May 2016, in their statement “Vision for Global Health”, the G7 leaders committed to taking concrete actions to advance global health, highlighting that health is the foundation of economic prosperity and security. These actions include among other commitments, the reinforcement of the Global Health Architecture to strengthen responses to public health emergencies and R&D and innovation. The G7 leaders “acknowledge the importance of ensuring mechanisms…Read more

Coordinating Funding in Public Health Emergencies, a correspondence* describing the activities of the GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) consortium, was published in The Lancet on May 27th. The letter highlights how GloPID-R’s 26 members are working to improve the coordination of global research efforts in public health emergencies. GloPID-R’s immediate response to the Zika outbreak in December 2015 is given as a successful example of the ambitious goal to initiate a coordinated international research response within 48…Read more